Hormonal Implants Technical Update June 23, Jeff Spieler Senior Technical Advisor for Science and Technology GH/PRH

Similar documents
Sino implant (II) Increasing Access by Introducing a Low Cost Contraceptive Implant

Contraceptive Security for Long-Acting and Permanent Contraception (LA/PMs), & the Compelling Case for the Postpartum IUD

FP: What s New, What s Hot, and What Does It Mean for LAC

Contraceptive Technology Update And is there an Unfinished Agenda? 2011 International Conference on FP December 1, 2011

Beginning with the End in Mind: Multiple Meanings for Contraceptive Research & Development. Kate Rademacher, Technical Advisor, FHI 360

The Contraceptive Implant: Global Evidence & Marie Stopes International s Experience. Martyn Smith 6 th September 2012

Does your family planning program need a Reality Check? Leah Jarvis, MPH Program Associate for Monitoring, Evaluation, and Research

An Illustrative Communication Strategy for Contraceptive Implants

Implants and ART: weighing the evidence to guide programs

Global Resources Required to Expand Family Planning Services in Low- and Middle-Income Countries. John Stover, Eva Weissman, September 2010 John Ross

Introducing the Contraceptive Sino Implant II (Zarin) in Sierra Leone. Background

Contraceptive. Ready Lessons II. What Can a Contraceptive Security Champion Do?

PMA2020: Progress & Opportunities for Advocacy AFP Partners Meeting & Gates Institute 15 th Anniversary Event

Long-Acting Contraception for the Developing World

Meeting Unmet Need and Increasing Contraceptive Options and Services with Postpartum Family Planning

FP2020 CORE INDICATOR ESTIMATES UGANDA

The Role of Family Planning in Meeting MDGs

To Tie the Knot or Not: A Case for Permanent Family Planning Methods

The What-nots and Why-nots of Unmet Need for FP Global Health Mini-University, September 14, 2012

Contraceptive Choice and Discontinuation in Selected African Countries: A Focus on Injectables*

Reintroducing the IUD in Kenya

The Private Sector: Key to Achieving Family Planning 2020 Goals

Vasectomy Overview. If Vasectomy Is Such a Good Method and It Is Why Has It Fared So Poorly in Our Family Planning Programs the Past 30 Years?

Implanon scale up & IUCD revitalization in Ethiopia

PPFP Global Meeting Follow-up Workshop. Country Posters

Pay ATTENTION to Reproductive INTENTION:

The Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial

Family Planning: Succeeding in Meeting Needs To Make a Better World. Amy Tsui April 12, 2011

USG Update on Family Planning/HIV Integration

Jadelle Levonorgestral Rod Implants: Profile and Lessons

Bill & Melinda Gates Institute for Population and Reproductive Health

Contraceptive Security: Incomplete without Long-Acting and Permanent Methods

Holistic Programming Leads to Sustained Increases in IUD Use in Kenya

Dr. Natella Rakhmanina Senior Technical Advisor, Elizabeth Glaser Pediatric AIDS Foundation October 2018

Introduction to the Family Planning Financing Roadmap

Hormonal contraception and HIV risk

Implant Programming. Marie Stopes International. Ghana. George Akanlu, Director Regional Operations. Click to edit footer free text field

impact dashboard - august 2018

impact dashboard - september 2018

PROMOTING VASECTOMY SERVICES IN MALAWI

RESEARCH. A forum for putting knowledge into practice

Scaling-Up Excellence

impact dashboard - june 2018

impact dashboard - may 2018

Population and Reproductive Health Challenges in Eastern and Southern Africa: Policy and Program Implications

DOES HORMONAL CONTRACEPTION INCREASE HIV ACQUISITION RISK AMONG ZAMBIAN WOMEN IN DISCORDANT COUPLES?

Hormonal Contraception and HIV Acquisition: Getting on the Same Page. Zambia October 2015

Contraception Choices: An Evidence Based Approach Case Study Approach. Susan Hellier PhD, DNP, FNP-BC, CNE

MSI experiences of Task Sharing tubal ligation by clinical officers in Zambia and Uganda

Zimbabwe Actions for Acceleration FP2020

The series will provide information on family planning methods, including how to use them, their effectiveness, how they work,

impact dashboard year-end with 2017 coefficients

Measurement of Access to Family Planning in Demographic and Health Surveys: Lessons and Challenges

East, Central and Southern Africa Health Community

Update on the Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial

Trends in Modern Contraceptive Prevalence Rate among Currently Married Women in Uganda:

ADVANCING PARTNERS & COMMUNITIES STANDARD DAYS METHOD CONSULTATION REPORT FEBRUARY 2015

Impact Dashboard - October 2014

Impact Dashboard - August 2014

Medical Eligibility for Contraception Use

RESEARCH. A forum for putting knowledge into practice

COUNTRY PROFILE: ZAMBIA ZAMBIA COMMUNITY HEALTH PROGRAMS DECEMBER 2013

Contraception for Adolescents: What s New?

Nelly Mugo, MBChB, MMed, MPH Kenya Medical Research Institute. May 2015

Access to Stigma-Free Healthcare Settings for Key Populations: Challenges and Opportunities

Malawi Family Planning Toolkit

COUNTRY PROFILE: ETHIOPIA ETHIOPIA COMMUNITY HEALTH PROGRAMS DECEMBER 2013

Sayana Press Introduction In Senegal: Strategies, Opportunities and Challenges

CONTRACEPTIVE SOCIAL MARKETING STATISTICS

Biases in Contraceptive Service Provision among Clinical and Non-Clinical Family Planning Provider Network Members in Nigeria

Contraception for Obese Women RENEE E. MESTAD, MD, MSCI ACOG DISTRICT II UPSTATE MEETING APRIL 29, 2016

Why do we need male contraceptive methods?

Copenhagen, Denmark September 2014

Promoting FP/RH-HIV/AIDS Integration: A Summary of Global Health Initiative Strategies in Ethiopia, Kenya, Tanzania, and Zambia

Public-Private Partnership in Family Planning

2015 CONTRACEPTIVE SOCIAL MARKETING STATISTICS

Integration of Contraceptive Counseling into HIV Services for Youth:

BLEEDING PATTERNS AND CONTRACEPTIVE DISCONTINUATION FG MHLANGA MTN ANNUAL MEETING 20 MARCH 2018

CONTRACEPTIVE SOCIAL MARKETING STATISTICS

MATERNAL, NEWBORN, AND CHILD HEALTH

2006 CONTRACEPTIVE SOCIAL MARKETING STATISTICS

Strategic Communication Framework for Hormonal Contraceptive Methods and Potential HIV-Related Risks. Beth Mallalieu October 22, 2015

What is the recent experience of programs that distribute contraceptives free of charge versus for a price?

Contraceptive Technology Update (CTU): What s s New Out There, What Are the Implications?

Measuring the Empty Shelf: Progress and Trends Using the Universal Stockout Indicator

Evidence on Hormonal Contraception & ART Interactions. HC-HIV Meeting Lusaka, Zambia October 22, 2015 Jennifer Tang, MD, MSCR

Exploring Contraceptive Use Differentials in Sub- Saharan Africa through a Health Workforce Lens

Using Mobile Outreach Services to Expand Access to Contraception in Ethiopia

The Evidence for Contraceptive Options and HIV Outcomes (ECHO) Study Questions and Answers

The Regional Centre of Excellence (CoE) on Programmatic Management of Drug Resistant Tuberculosis (PMDT)

Expanding Access to Injectable Contraception Geneva, June 2009

Evaluating a LARC Expansion Program in 14 Sub-Saharan African Countries: A Service Delivery Model for Meeting FP2020 Goals

HIV/AIDS and Fertility

FP2020 Expert Advisory Community Webinar

Elements of Reproductive Health

Contraceptive Trends in the Developing World: A Comparative Analysis from the Demographic and Health Surveys

HIV/AIDS Country Publications

Postabortion Family Planning: A Glimpse of Global Evidence and its Impact with Country Implementation. April 14, 2016

Fertility and Family Planning in Africa: Call for Greater Equity Consciousness

The Curious Case of Ghana: Can Reproductive Health Laws Help to Explain the Gap Between Contraceptive Use and Fertility Decline?

Transcription:

Hormonal Implants Technical Update June 23, 2009 Jeff Spieler Senior Technical Advisor for Science and Technology GH/PRH

TOPICS: Elements of Successful FP Programs LAPMs Implants Introduction to the Implant Toolkit

Elements of Successful FP Programs Supportive government policies Evidence-based programming Strong leadership & good management Effective communication & outreach strategies Contraceptive supply & logistics system Well-trained, supervised & motivated staff Client-centered care for all groups Mix of service delivery points Free or inexpensive services for poor Integration with related health services

Long-Acting & Permanent Methods

Characteristics of LAPMs Highly effective Long lasting High continuation / low discontinuation Cost-effective Wide eligibility

Ethiopia Ghana Kenya Madagascar Malawi Mali Nigeria Rwanda Senegal Tanzania Uganda Zambia Zimbabwe 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% mcpr and Proportion of Unmet Need for Limiting and Spacing (most recent DHS) 14.2 14.1 31.5 18.3 38.3 6.9 8.2 10.3 10.3 20 17.9 Limit Space 25.3 58.4 (mcpr)

Long-Lasting Duration of Effectiveness Female Sterilization remainder of fertile years Male Sterilization effective after 3 months for remainder of fertile years Copper containing IUDs 12 years Hormone containing IUDs 5 years Norplant 7 years Sino-Implant (II) 4 years (+) Jadelle 5 years Implanon 3 years (+?)

Long-Acting Contraceptives are Cost-Effective 25 US$ 20 15 10 5 Condoms Pills Depo IUCD Jadelle Norplant 0 At First Visit After 1 Year After 2 Years After 3 years After 4 years After 5 years

Sino-implant vs. Jadelle and Implanon Sino-implant (II) Jadelle Implanon Manufacturer Formulation Shanghai Dahua Pharmaceutical 2 rods; 75 mg levonorgestrel Bayer HealthCare 2 rods; 75 mg levonorgestrel Schering Plough/ Organon 1 rod; 68 mg etonogestrel Dimensions 2.4 mm x 44 mm 2.5 mm x 43 mm 2 mm x 40 mm Labeled length of use 4 years 5 years 3 years Trocars Disposable Autoclavable/ Disposable Cost of implant (US$) Cost per Year* Pre-loaded disposable $7.50 - $8.50 $21 - $23 $20 - $28 *Cost per Year assumes implant used for labeled use life $1.90-2.10 $4.20 - $4.60 $6.70 - $9.30 9

$16.00 $14.00 $12.00 Direct Cost per CYP by Method, 13 FP/RH Tier One Countries Cost/CYP $10.00 $8.00 $6.00 $4.00 $2.00 $0.00 IUD Sino - implant Generic DMPA DMPA COC Jadelle Implanon 10

Strategies for quality and successful scale-up Implant Scale-up Advocacy Adequate pre-counseling leading to informed choice Trained Providers A robust clinical infrastructure Steady and increasing supply of implants Client information about timing of removal Reliable access to removal Demand creation through Community awareness and participation Appropriate supervision and evaluation

Implant Toolkit Modeled after and adapted from the IUD toolkit; hosted by INFO at JHU/CCP The implants toolkit will be an expert-filtered electronic toolkit maintained and hosted on the K4H Web portal It will contain state-of-the-art information and resources on hormonal implants The purpose is to ensure that the primary audience has the information and tools they need to know about and to provide implants The primary audiences are Program managers Health care providers Policy makers at the local, regional and national levels Trainers, especially those involved in managing or implementing pre-service training Information officers in a position to facilitate use of the materials by program managers and health care providers

Implant Toolkit (continued) USAID has asked EH, FHI; and JHU/CCP to serve as the initiating partners Others CAs and technical experts from the larger family planning community, many of whom are here today will be invited to join working groups Significant progress has been made to date and Ruwaida Salem from the K4H Project will give us a short demonstration and toward the end of the meeting you ll have a chance to sign-up for content area working groups